Literature DB >> 3015376

6q- and loss of the Y chromosome--two common deviations in malignant human salivary gland tumors.

G Stenman, J Sandros, R Dahlenfors, M Juberg-Ode, J Mark.   

Abstract

Nine cases of malignant human salivary gland tumors cultured in vitro were subjected to detailed cytogenetic analysis with G-banding. Together with observations from three earlier published cases, the results of 12 cases were surveyed: five adenoid cystic carcinomas, three acinic cell tumors, three adenocarcinomas, and one mucoepidermoid carcinoma. All tumors had stemlines in the diploid-near-diploid mode. The most consistent changes among the adenoid cystic carcinomas were stem lines and/or variant cells with anomalies affecting the terminal part of 6q (i.e., 6q 16-25). Deviations affecting the Y chromosome (losses) and, to a lesser extent, #6 (structural changes) and #8 (gains) characterized the early karyotypic evolution in acinic cell tumors. Two of the three analyzed adenocarcinomas showed stemlines or variant cells with loss of gonosomes. The karyotypic features of the different tumor types, including primary changes, evolutionary characteristics, and progressional pathways, are discussed. The cytogenetic relationships between benign and malignant salivary gland tumors also will be considered.

Entities:  

Mesh:

Year:  1986        PMID: 3015376     DOI: 10.1016/0165-4608(86)90021-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  20 in total

1.  Plasma cell membrane glycoprotein gene Pca-1 (alkaline phosphodiesterase I) is linked to the proto-oncogene Myb on mouse chromosome 10.

Authors:  M F Buckley; J W Goding
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

Review 3.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

4.  Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

Authors:  Laura T Smith; Mauting Lin; Romulo M Brena; James C Lang; David E Schuller; Gregory A Otterson; Carl D Morrison; Dominic J Smiraglia; Christoph Plass
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

Review 5.  The emerging complexity of gene fusions in cancer.

Authors:  Fredrik Mertens; Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

6.  Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue.

Authors:  Diana Bell; Yi-Jue Zhao; Pulivarthi H Rao; Randal S Weber; Adel K El-Naggar
Journal:  Head Neck Pathol       Date:  2007-10-26

7.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

8.  [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].

Authors:  A Fehr; G Stenman; J Bullerdiek; T Löning
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

9.  Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation.

Authors:  Adriana Handra-Luca; Hadi Bilal; Jacques-Charles Bertrand; Pierre Fouret
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 10.  Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.

Authors:  Alison M Schram; Matthew T Chang; Philip Jonsson; Alexander Drilon
Journal:  Nat Rev Clin Oncol       Date:  2017-08-31       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.